FOSUN BIOPHARMACEUTICAL PARTNERING AND CAREER FORUM

  • Job Fair Bot
  • Stanford, CA
  • Apr 01, 2018
Multi-Employer General Business

Event Description

Shanghai Fosun Pharmaceutical (Group) Co, Ltd and Xuzhou Economic and Technological Development Zone will bring you this exciting networking opportunity with figured with opportunities for collaboration, investment and career development! The event is organized by CABS Title Sponsor: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. Founded at 1994, Shanghai Fosun Pharmaceutical (Group) Co. Ltd is becoming a leading healthcare group in China.Its business coversthe key sectors of healthcare value chain,including drug manufacture and R&D, medical service, medical device and diagnosis, pharmaceutical distribution and retail.Fosun Pharma has anational enterprise technology center,and has built a high-efficiency chemical innovation drug platform, biopharmaceutical platform, high-value added generic drug platform and cellular immunity platform. So far,Fosun Pharmahas the leading advantages in the market segments of blood circulation system, central nervous system, metabolism & digestive system, anti-infection, cardiovascular, oncology etc. With the brand conceptof innovation for good health, Fosun Pharmais committed to becoming the worlds leading healthcare enterprise. In 2017 alone,Fosun Pharmahad the revenue of18.5 billion,1.5 billion for R&D fund, and its market cap exceeded100 billion. Fosun has been pursuing an international cooperative strategy, and has diversified & flexible investment cooperation models. For examples,Fosun Pharmaacquired 74% stake in Gland Pharma for over $1 billion in 2017, and set up a joint-venture with Kite Pharma to developand commercialize autologous T-Cell therapies to treat cancer,Yescarta is expected to become the first cell therapy product. Leads by Mr. Yifang Wu, President and CEO of FosunPharma, the Bay Area promotional career forum hopes to have in-depth exchanges todiscussglobal cooperation andstrategic blueprintwith scientists, entrepreneurs and investors in the field of life sciences. Experts, students, scholars, entrepreneurs and investors with the interests of human medicine & healthcare areallwelcome to attend. Yifang Wu Executive Director of Fosun Pharma President of Fosun Pharma Chief Executive Officer of Fosun Pharma Mr. Yifang Wu, joined Fosun in April 2004 and now serves as President and Chief Executive Officer of Fosun Pharma. Mr. Wu used to serve as a Technician, Director, Production Officer, Finance Director, Assistant to Director of Xuzhou Biochemical Pharmaceutical Factory, now known as Wanbang Pharma, from June 1987 to April 1997, Deputy Director of Xuzhou (Wanbang) Biopharmaceuticals Manufactures Plant, now known as Wanbang Pharma, from April 1997 to December 1998, President of Xuzhou Wanbang Biochemical Pharmaceutical Co., Ltd. , now known as Wanbang Pharma, Deputy General Manager of Wanbang Pharma from December 1998 to March 2007, President of Wanbang Pharma, from March 2007 to April 2011, and Chairman and CEO of Wanbang Pharma from April 2011 till now. Mr. Wu was Vice President and Chief Operation Director of Fosun Pharma from July 2014 to January 2016 and has been President and Chief Executive Officer of Fosun Pharma since June 2016, as well as Executive Director since August 2016. Xuzhou Economic and Technological Development Zone Xuzhou Economic and Technological Development Zone lies in important strategic position of the "four vertical and four horizontal" system of the national railway network and is an important channel connecting the Beijing-Hangzhou Grand Canal Economical Belt and the Yangtze River Economical Belt. Founded in July 1992 covering an area of 293.6 square kilometers, Xuzhou Economic and Technological Development Zone has has upgraded to a state-level Economic and Technological Development Zone in March 2010. So far there are 4125 enterprises including 13 Fortune 500 companies in the zone. Currently Xuzhou Economic and Technological Development Zones comprehensive strength ranks 7th provincially of all 137 Development Zones in Jiangsu and has became a zone with largest scale, strongest strength, highest industry grade and of most investment value around Huaihai Economic Region. Career Forum Figured Participating Companies: 1) Biocytogen Inc.headquartered in Beijing is one of the global leaders in gene targeted animial model production, preclinical in vivo efficacy studies and pharmacological service. Opening positions(United States): In vivo efficacy/Toxicity Director PK/PD Scientists PK/PD Research Associates BD Director or Manager 2Applied StemCell Inc. (ASC)is a fast growing biotechnology company headquartered in Milpitas, California. Our goal is to advancegene-editing and stem cell innovationfor biomedical research and the biotechnology industry. After years of research and development, ASC is proud to offer an optimized series of tools for basic research study, drug discovery, bio-processing, bio-production and preclinical applications. We are currently focusing on three areas: (1) cell line generation for bio-production and bioassays (2) patient-relevant cell models for personalized medicine and (3) physiologically predictive animal models of human diseases. We are striving to improve and expand our technologies and product lines to meet the increasing requirements of the biomedical community. Opening positions(United States): Scientist in Molecular Biology and Cell Genome Editing Scientist in R&D Department Scientist in Product Development Department Scientist, Therapeutic Development Research Associate (R&D Department) Research Associate Research Associate, Therapeutic development Research Associate, Genome Editing/ Engineering 3)Kelun Pharmaceutical Founded in 1996, with over 100 subsidiaries globally; a public-traded company; one of the top 10 pharmaceutical companies in China with over 6 billion USD revenue in 2016 Kelun Pharmaceutical Research Institute Over 1,300 R&D scientists; headquartered in Chengdu China with satellite research centers in Tianjin, Suzhou, and New Jersey; platforms include innovative small molecules and biologics, generic drugs, and new drug delivery systems; focusing on cancer, diabetes, liver, CNS, cardiovascular and autoimmune diseases, etc;looking for in-licensing opportunities in biologics, cell therapy, oncolytic virus therapy, therapeutic nucleic acids, new drug delivery systems, small molecules for combination therapies. Opening positions The Clinical Strategy Lead (CSL) Director, Early Stage Clinical Development Director, Late Stage Clinical Development Director, Clinical Operation Head Clinical Trials Liaison Officer (CTLO) Biologics Production Executive Director Director, Biologics Process Development Director of Biologics QA Director of Formulation Development Director of Generics FormulationSolid Oral Products or Injectables More companies will be updated close to the event. Event Schedule: 2:00 pm-2:30pm registration Main Section: 2:30 pm - 2:40 pm Opening remarks: CABS, Dr. Cheni Kwok 2:40 pm 3: 10 pm Keynote speech: Yifang Wu, President & CEO, Shanghai Fosun Pharmaceutical (Group) Co.,Ltd 3:10 pm - 3: 30 pm To be determined. Career fair section: 3:30pm - 3:40 pm Biocytogen Inc. 3:40pm - 3:50 pm Applied StemCell Inc. 3:50pm 4: 00 pm Kelun Pharmaceutical Career fair and networking: 4:00 pm - 5: 30 pm Schedule may be different on the day. Full job opening list and event detail will be released one week before event.

Event Date

Apr 14, 2018